Key steps
More and more developers are utilizing antibodies to drive the development of tomorrows biotechnological breakthroughs. With a year-on-year growth rate of 12.3%, the market is now worth in excess of $7.5 billion with new life changing antibody therapies and powerful reagent use driving continued uptake.
From selection to purification, polyclonal antibody production must follow key steps to achieve antibodies with the purity and quantity needed for research and production.
Today, Inotiv delivers: Monoclonal and polyclonal antibody production; Hybridoma development; Immunogenicity immunization; Antibody purification; Mouse antibody production (MAP) testing.
Download the next infographic in the series
Get the second in a series of infographics, charting the history, production strategies and technology challenges faced when producing antibodies for research and manufacture. These resources provide insights collated from Inotiv’s long history in antibody production, with quick reference production strategies and useful reminders of the challenges commonly faced by researchers and production engineers.
